149 related articles for article (PubMed ID: 20667095)
1. Effects of MCF2L2, ADIPOQ and SOX2 genetic polymorphisms on the development of nephropathy in type 1 Diabetes Mellitus.
Zhang D; Efendic S; Brismar K; Gu HF
BMC Med Genet; 2010 Jul; 11():116. PubMed ID: 20667095
[TBL] [Abstract][Full Text] [Related]
2. SOX2 has gender-specific genetic effects on diabetic nephropathy in samples from patients with type 1 diabetes mellitus in the GoKinD study.
Gu HF; Alvarsson A; Efendic S; Brismar K
Gend Med; 2009 Dec; 6(4):555-64. PubMed ID: 20114006
[TBL] [Abstract][Full Text] [Related]
3. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.
Zhang D; Ma J; Brismar K; Efendic S; Gu HF
J Diabetes Complications; 2009; 23(4):265-72. PubMed ID: 18599322
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin gene (ADIPOQ) polymorphisms correlate with the progression of nephropathy in Taiwanese male patients with type 2 diabetes.
Chung HF; Long KZ; Hsu CC; Mamun AA; Chiu YF; Tu HP; Chen PS; Jhang HR; Hwang SJ; Huang MC
Diabetes Res Clin Pract; 2014 Aug; 105(2):261-70. PubMed ID: 24894086
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin gene polymorphisms in Egyptian type 2 diabetes mellitus patients with and without diabetic nephropathy.
El-Shal AS; Zidan HE; Rashad NM
Mol Biol Rep; 2014; 41(4):2287-98. PubMed ID: 24469713
[TBL] [Abstract][Full Text] [Related]
6. IGF2BP2 and IGF2 genetic effects in diabetes and diabetic nephropathy.
Gu T; Horová E; Möllsten A; Seman NA; Falhammar H; Prázný M; Brismar K; Gu HF
J Diabetes Complications; 2012; 26(5):393-8. PubMed ID: 22770937
[TBL] [Abstract][Full Text] [Related]
7. Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene.
Vionnet N; Tregouët D; Kazeem G; Gut I; Groop PH; Tarnow L; Parving HH; Hadjadj S; Forsblom C; Farrall M; Gauguier D; Cox R; Matsuda F; Heath S; Thévard A; Rousseau R; Cambien F; Marre M; Lathrop M
Diabetes; 2006 Nov; 55(11):3166-74. PubMed ID: 17065357
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the association between the common E469K polymorphism in the ICAM-1 gene and diabetic nephropathy among type 1 diabetic patients in GoKinD population.
Ma J; Zhang D; Brismar K; Efendic S; Gu HF
BMC Med Genet; 2008 May; 9():47. PubMed ID: 18505543
[TBL] [Abstract][Full Text] [Related]
9. TNF-α (g.-308 G > A) and ADIPOQ (g. + 45 T > G) gene polymorphisms in type 2 diabetes and microvascular complications in the region of Punjab (North-West India).
Sikka R; Raina P; Matharoo K; Bandesh K; Bhatia R; Chakrabarti S; Bhanwer AJ
Curr Eye Res; 2014 Oct; 39(10):1042-51. PubMed ID: 24655058
[TBL] [Abstract][Full Text] [Related]
10. Distribution of neuropeptide Y Leu7Pro polymorphism in patients with type 1 diabetes and diabetic nephropathy among Swedish and American populations.
Ma J; Nordman S; Möllsten A; Falhammar H; Brismar K; Dahlquist G; Efendic S; Gu HF
Eur J Endocrinol; 2007 Nov; 157(5):641-5. PubMed ID: 17984244
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in the matrix metalloproteinase genes and diabetic nephropathy in type 1 diabetes.
Kure M; Pezzolesi MG; Poznik GD; Katavetin P; Skupien J; Dunn JS; Mychaleckyj JC; Warram JH; Krolewski AS
Mol Genet Metab; 2011 May; 103(1):60-5. PubMed ID: 21277817
[TBL] [Abstract][Full Text] [Related]
12. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
[TBL] [Abstract][Full Text] [Related]
13. Genetic association analysis of the adiponectin polymorphisms in type 1 diabetes with and without diabetic nephropathy.
Ma J; Möllsten A; Falhammar H; Brismar K; Dahlquist G; Efendic S; Gu HF
J Diabetes Complications; 2007; 21(1):28-33. PubMed ID: 17189871
[TBL] [Abstract][Full Text] [Related]
14. Association and interaction analyses of genetic variants in ADIPOQ, ENPP1, GHSR, PPARgamma and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetes.
Wu LS; Hsieh CH; Pei D; Hung YJ; Kuo SW; Lin E
Nephrol Dial Transplant; 2009 Nov; 24(11):3360-6. PubMed ID: 19506043
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of genetic association and expression reduction of TRPC1 in the development of diabetic nephropathy.
Zhang D; Freedman BI; Flekac M; Santos E; Hicks PJ; Bowden DW; Efendic S; Brismar K; Gu HF
Am J Nephrol; 2009; 29(3):244-51. PubMed ID: 18802326
[TBL] [Abstract][Full Text] [Related]
16. Chronic Kidney Disease: Interaction of Adiponectin Gene Polymorphisms and Diabetes.
Chen HH; Huang YL; Chen MC; Wu CY; Lin YC; Shiue HS; Hsu SL; Hsueh YM
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175838
[TBL] [Abstract][Full Text] [Related]
17. High-density single nucleotide polymorphism genome-wide linkage scan for susceptibility genes for diabetic nephropathy in type 1 diabetes: discordant sibpair approach.
Rogus JJ; Poznik GD; Pezzolesi MG; Smiles AM; Dunn J; Walker W; Wanic K; Moczulski D; Canani L; Araki S; Makita Y; Warram JH; Krolewski AS
Diabetes; 2008 Sep; 57(9):2519-26. PubMed ID: 18559660
[TBL] [Abstract][Full Text] [Related]
18. Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis.
Moczulski DK; Rogus JJ; Antonellis A; Warram JH; Krolewski AS
Diabetes; 1998 Jul; 47(7):1164-9. PubMed ID: 9648845
[TBL] [Abstract][Full Text] [Related]
19. New susceptibility loci associated with kidney disease in type 1 diabetes.
Sandholm N; Salem RM; McKnight AJ; Brennan EP; Forsblom C; Isakova T; McKay GJ; Williams WW; Sadlier DM; Mäkinen VP; Swan EJ; Palmer C; Boright AP; Ahlqvist E; Deshmukh HA; Keller BJ; Huang H; Ahola AJ; Fagerholm E; Gordin D; Harjutsalo V; He B; Heikkilä O; Hietala K; Kytö J; Lahermo P; Lehto M; Lithovius R; Osterholm AM; Parkkonen M; Pitkäniemi J; Rosengård-Bärlund M; Saraheimo M; Sarti C; Söderlund J; Soro-Paavonen A; Syreeni A; Thorn LM; Tikkanen H; Tolonen N; Tryggvason K; Tuomilehto J; Wadén J; Gill GV; Prior S; Guiducci C; Mirel DB; Taylor A; Hosseini SM; ; Parving HH; Rossing P; Tarnow L; Ladenvall C; Alhenc-Gelas F; Lefebvre P; Rigalleau V; Roussel R; Tregouet DA; Maestroni A; Maestroni S; Falhammar H; Gu T; Möllsten A; Cimponeriu D; Ioana M; Mota M; Mota E; Serafinceanu C; Stavarachi M; Hanson RL; Nelson RG; Kretzler M; Colhoun HM; Panduru NM; Gu HF; Brismar K; Zerbini G; Hadjadj S; Marre M; Groop L; Lajer M; Bull SB; Waggott D; Paterson AD; Savage DA; Bain SC; Martin F; Hirschhorn JN; Godson C; Florez JC; Groop PH; Maxwell AP
PLoS Genet; 2012 Sep; 8(9):e1002921. PubMed ID: 23028342
[TBL] [Abstract][Full Text] [Related]
20. Cubilin Single Nucleotide Polymorphism Variants are Associated with Macroangiopathy While a Matrix Metalloproteinase-9 Single Nucleotide Polymorphism Flip-Flop may Indicate Susceptibility of Diabetic Nephropathy in Type-2 Diabetic Patients.
Albert C; Kube J; Albert A; Schanze D; Zenker M; Mertens PR
Nephron; 2019; 141(3):156-165. PubMed ID: 30557881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
